Malvina Prapa
Modena, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Autologous anti-GD2 CAR T cells efficiently target primary human glioblastoma.
Journal: NPJ precision oncology
Published: February 22, 2023
Impact of soluble tumor necrosis factor-related apoptosis-inducing ligand released by engineered adipose mesenchymal stromal cells on white blood cells.
Journal: Cytotherapy
Published: September 01, 2022
Anti-GD2 CAR MSCs against metastatic Ewing's sarcoma.
Journal: Translational oncology
Published: June 17, 2021
GD2 CAR T cells against human glioblastoma.
Journal: NPJ precision oncology
Published: January 14, 2021
Developing cell therapies as drug products.
Journal: British journal of pharmacology
Published: September 03, 2020
Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitors.
Journal: Cancer gene therapy
Published: August 23, 2018
Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer.
Journal: Scientific reports
Published: August 31, 2017
A novel anti-GD2/4-1BB chimeric antigen receptor triggers neuroblastoma cell killing.
Journal: Oncotarget
Published: May 11, 2015
Detection of microparticles from human red blood cells by multiparametric flow cytometry.
Journal: Blood transfusion = Trasfusione del sangue
Published: June 02, 2014
Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomas.
Journal: Stem cells (Dayton, Ohio)
Published: April 29, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026